Home About Integrative Medicine Center of Georgia Medical Services null Become a Patient Patient Account Medical Tourism For Physicians Contact Us
Medical Services
Chronic Non-Healing Wounds, Bed Sores and Ulcers
Chronic Infections
Antibiotic-Resistant Infections
Phage Therapy
NovoMed Treatment Platform Technologies
Biodegradable Polymers

NovoMed Treatment Platform Technologies

In many situations phage therapy can be superior to antibiotics. This is particularly true in wound care applications, treatment of osteomyelitis and chronic infections.

Wound Care

Wound infection is a common risk for patients with chronic nonhealing wounds, causing high morbidity and mortality. Currently, systemic antibiotic treatment is the therapy of choice, despite often leading to several side effects and the risk of an insufficient tissue penetration due to impaired blood supply (typicaly in diabetics).

Antibiotic drug resistance and skin wound infection are a growing concern in all parts of wound management. The risk of wound infection increases as disorders in the local environment (e.g., blood supply and eschar) favor bacterial growth rather than host defense. This can lead to impaired wound healing, bacteremia, or even sepsis and is associated with high morbidity and mortality.

Today's mainstay for the treatment of wound infection is systemic antibiotic therapy, even though it is associated with increased development of antibiotic drug resistance and adverse side effects. Moreover, most systemic agents have poor tissue penetration; for example, in burn wounds, blood vessels, which normally carry a systemic antibiotic to the wound, are destroyed.

Topical antibiotics are also very important but currently limited in their clinical use. To date, no topical broad-spectrum antibiotic with FDA approval is available for the treatment of skin wound infections.

Treatment of Chronic Wounds

In wound care applications, after normal debridement procedures, bacteriophages are applied directly to the wound and are highly effective toward clearing Staphylococcus aureus, Pseudomonas aeruginosa and other pathogens from the wound. Application is performed by wetting the bandage with a liquid phage preparation.


Amino acid based biodegradable polymers imbedded with bacteriophages significantly enhance the treatment process, as follows:

  • biodegradable polymers are absorbed by the body, leaving no toxic byproducts;
  • as the polymers biodegrade on the wound, phages are continuously eluted, providing a constant application of the medication;
  • the amino acids have anti-inflammatory and growth-factor properties; and
  • there are significantly fewer bandage changes thereby reducing treatments costs; there is less pain and discomfort to the patient due to reduced number of bandage changes.


Osteomyelitis is generally treated by the systemic administration of antibiotics and continuous irrigation after curettage of the lesion, and bone graft is performed secondarily to treat any bone defect. This treatment is associated with major invasion, and also has adverse effects on other organs. There is little high quality evidence on the relative effectiveness of various regimens of antibiotic therapy for osteomyelitis or septic arthritis.

Treatment of Osteomyelitis

Treatment of osteomyelitis with phage therapy typically begins with irrigation (depending the diagnosis), as is the case with antibiotic therapies, however the patient does not suffer adverse effects of antibiotics. Given that biodegrable polymers are fully absorbable and produce no toxic byproducts, the time required for irrigations can be reduced or eliminated by applying the polymers then closing the incision; the polymers will continue to elute bacteriophages and other medications for an extended period.

Chronic Infections

A biofilm is a structured consortium of bacteria embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. Bacterial biofilms cause chronic infections because they show increased tolerance to antibiotics and disinfectant chemicals as well as resisting phagocytosis and other components of the body's defence system. The persistence of, for example, staphylococcal infections related to foreign bodies is due to biofilm formation. Likewise, chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is caused by biofilm-growing mucoid strains.

Treatment of Chronic Infections

Treatment of chronic infections typically requires "complex therapy", meaning that a combination of bacteriophages and other medications are expertly combined to help clear the biofilm and underlying infection. In very difficult cases, treatment can require several courses of treatment over some years; however, much improvement is realized in cases of chronic UTI's, chronic prostatitis and chronic sinusits.


Efficacy of Topically Delivered Moxifloxacin against Wound Infection by Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother. May 2011 vol. 55 no. 5 2325-2334
F. Jacobsen, C. Fisahn1, M. Sorkin, I. Thiele1, T. Hirsch, I. Stricker, T. Klaassen, A. Roemer, B. Fugmann and L. Steinstraesser

Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?
International Journal of Infectious Diseases, Volume 9, Issue 3 , Pages 127-138, May 2005
Luca Lazzarini, Benjamin A. Lipsky, Jon T. Mader

Antibiotic resistance of bacterial biofilms
International Journal of Antimicrobial Agents Volume 35, Issue 4, April 2010, Pages 322–332
Niels Høibya, Thomas Bjarnsholt, Michael Givskov, Søren Molin, Oana Ciofu